Pharma Guy

Patient engagement can shift throughout the treatment journey. Recognizing where those changes occur could help pharma marketers deliver more relevant communication and support stronger medication adherence. Read more: pharma-mkting.com/articles/p… #MedicationAdherence #PatientEngagement

Patient drop off may not happen without warning. Predictive adherence strategies could help pharma marketers identify early signs of disengagement and provide more relevant support before patients abandon therapy. Read more: pharma-mkting.com/articles/p… #PharmaMarketing #PatientEngagement #MedicationAdherence #HealthcareAI

Some patients may remain hidden within traditional healthcare data. Predictive patient identification can help uncover patterns that may provide a clearer picture of patient populations and unmet needs. Read more: pharma-mkting.com/articles/p… #PharmaMarketing #PredictiveAnalytics #PatientInsights #HealthcareData

What if the next patient hasn’t been diagnosed yet? Predictive analytics could help pharma marketers identify gaps in disease awareness earlier, opening new opportunities for relevant patient education. Read more: pharma-mkting.com/articles/p… #PharmaMarketing #PredictiveAnalytics #PatientMarketing #HealthcareData

More disclosure requirements could change the economics and creative approach behind pharma TV advertising. For marketers, the impact may extend beyond the commercial itself to broader media planning. Read more: pharma-mkting.com/articles/p… #PharmaMarketing #FDA #PharmaAdvertising

New FDA rules could reshape pharma TV advertising, affecting disclosure requirements, costs, and media strategy. Read more: pharma-mkting.com/articles/p… #PharmaMarketing #FDA #PharmaAdvertising

#DHCdisrupt panel in NYC on how AI and data are improving media execution to meet patients where they are, when they need your brand @RealChemistry_ @pulsepoint @WPP @argenxglobal

Agentic Pharma Summit. Nov. 9 and 10 in Philadelphia. Two days with the commercial leaders putting agentic AI to work across pharma. agenticpharmasummit.com/?utm… #AgenticAI #PharmaMarketing

Programmatic campaigns rely on more than media placement. Data access, audience reach, and partner stability all play a role. For pharma marketers, planning for disruption is becoming an important part of managing ad tech risk. Read more: pharma-mkting.com/articles/p… #PharmaMarketing #ProgrammaticAdvertising #AdTech

24 sessions focused on agentic AI in pharma commercial. Agentic Pharma Summit brings pharma leaders to Philadelphia Nov. 9 and 10, including keynote speaker Anna Berg Asberg of Gilead Sciences. agenticpharmasummit.com/?utm… #AgenticAI #PharmaCommercial

What happens when a key ad tech partner fails? For pharma marketers, understanding programmatic risk can help protect campaigns and media investments. Read more: pharma-mkting.com/articles/p… #PharmaMarketing #ProgrammaticAdvertising #AdTech

Biosimilar adoption comes with a unique marketing challenge: standing out in an increasingly complex market. The right strategy can help marketers navigate competition, strengthen confidence, and communicate meaningful value to key audiences. Read more: pharma-mkting.com/articles/b… #PharmaMarketing #Biosimilars #PharmaStrategy #HealthcareMarketing

Agentic Pharma Summit, Nov. 9 and 10, Philadelphia. 24 sessions on agentic AI in pharma commercial with leaders from Gilead, Pfizer, Sanofi, AstraZeneca and more. agenticpharmasummit.com/?utm… #AgenticAI #PharmaMarketing

As more biosimilars enter the market, strong marketing requires more than competing on price. Clear education and credible messaging can help build confidence among HCPs and patients. Read more: pharma-mkting.com/articles/b… #PharmaMarketing #Biosimilars #HealthcareMarketing

Reality check from Ray Frost (Cogent Biosciences): first-to-market in rare disease ≠ easy. Payers still deny, physicians often don't know the disease state, and diagnosis alone can take up to 7 years. #lsproductlaunch

Pharma trust is being measured differently. Reputation still matters, but relevance and real-world impact are increasingly shaping how patients and HCPs view credibility. Read more: pharma-mkting.com/featured/n… #PharmaMarketing #PharmaTrust #HealthcareMarketing #BrandStrategy

"Launch Synchrony" — once you're in launch, you can only change so much. Lawrence Bressler (Chiesi) on why Commercial, Medical, and Access have to align 18–24 months before day one, not during it. #lsproductlaunch